Literature DB >> 12702496

Enteral glutamine stimulates protein synthesis and decreases ubiquitin mRNA level in human gut mucosa.

Moïse Coëffier1, Sophie Claeyssens, Bernadette Hecketsweiler, Alain Lavoinne, Philippe Ducrotté, Pierre Déchelotte.   

Abstract

Effects of glutamine on whole body and intestinal protein synthesis and on intestinal proteolysis were assessed in humans. Two groups of healthy volunteers received in a random order enteral glutamine (0.8 mmol.kg body wt(-1)x h(-1)) compared either to saline or isonitrogenous amino acids. Intravenous [2H5]phenylalanine and [13C]leucine were simultaneously infused. After gas chromatography-mass spectrometry analysis, whole body protein turnover was estimated from traced plasma amino acid fluxes and the fractional synthesis rate (FSR) of gut mucosal protein was calculated from protein and intracellular phenylalanine and leucine enrichments in duodenal biopsies. mRNA levels for ubiquitin, cathepsin D, and m-calpain were analyzed in biopsies by RT-PCR. Glutamine significantly increased mucosal protein FSR compared with saline. Glutamine and amino acids had similar effects on FSR. The mRNA level for ubiquitin was significantly decreased after glutamine infusion compared with saline and amino acids, whereas cathepsin D and m-calpain mRNA levels were not affected. Enteral glutamine stimulates mucosal protein synthesis and may attenuate ubiquitin-dependent proteolysis and thus improve protein balance in human gut.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12702496     DOI: 10.1152/ajpgi.00385.2002

Source DB:  PubMed          Journal:  Am J Physiol Gastrointest Liver Physiol        ISSN: 0193-1857            Impact factor:   4.052


  16 in total

1.  Role of Glutamine in Protection of Intestinal Epithelial Tight Junctions.

Authors:  RadhaKrishna Rao; Geetha Samak
Journal:  J Epithel Biol Pharmacol       Date:  2012-01

2.  Long-term intermittent glutamine supplementation repairs intestinal damage (structure and functional mass) with advanced age: assessment with plasma citrulline in a rodent model.

Authors:  A M Beaufrère; N Neveux; P Patureau Mirand; C Buffière; G Marceau; V Sapin; L Cynober; D Meydinal-Denis
Journal:  J Nutr Health Aging       Date:  2014-11       Impact factor: 4.075

3.  Glutamine protects against apoptosis via downregulation of Sp3 in intestinal epithelial cells.

Authors:  Kechen Ban; Rosemary A Kozar
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2010-09-30       Impact factor: 4.052

4.  Glutamine supplementation in sick children: is it beneficial?

Authors:  Elise Mok; Régis Hankard
Journal:  J Nutr Metab       Date:  2011-11-14

Review 5.  Maximizing efficacy from parenteral nutrition in critical care: appropriate patient populations, supplemental parenteral nutrition, glucose control, parenteral glutamine, and alternative fat sources.

Authors:  Paul E Marik
Journal:  Curr Gastroenterol Rep       Date:  2007-08

6.  Effects of glutamine supplementation on gut barrier, glutathione content and acute phase response in malnourished rats during inflammatory shock.

Authors:  Liliana Belmonte; Moïse Coëffier; Florence Le Pessot; Olga Miralles-Barrachina; Martine Hiron; Antony Leplingard; Jean-François Lemeland; Bernadette Hecketsweiler; Maryvonne Daveau; Philippe Ducrotté; Pierre Déchelotte
Journal:  World J Gastroenterol       Date:  2007-05-28       Impact factor: 5.742

7.  A diet containing whey protein, glutamine, and TGFbeta modulates gut protein metabolism during chemotherapy-induced mucositis in rats.

Authors:  Nabile Boukhettala; Ayman Ibrahim; Sophie Claeyssens; Magali Faure; Florence Le Pessot; Jacques Vuichoud; Alain Lavoinne; Denis Breuillé; Pierre Déchelotte; Moïse Coëffier
Journal:  Dig Dis Sci       Date:  2009-11-13       Impact factor: 3.199

Review 8.  Glutamine randomized studies in early life: the unsolved riddle of experimental and clinical studies.

Authors:  Efrossini Briassouli; George Briassoulis
Journal:  Clin Dev Immunol       Date:  2012-09-18

9.  Role of toll like receptors in irritable bowel syndrome: differential mucosal immune activation according to the disease subtype.

Authors:  Liliana Belmonte; Stéphanie Beutheu Youmba; Nathalie Bertiaux-Vandaële; Michel Antonietti; Stéphane Lecleire; Alberto Zalar; Guillaume Gourcerol; Anne-Marie Leroi; Pierre Déchelotte; Moïse Coëffier; Philippe Ducrotté
Journal:  PLoS One       Date:  2012-08-17       Impact factor: 3.240

10.  Low intestinal glutamine level and low glutaminase activity in Crohn's disease: a rational for glutamine supplementation?

Authors:  Bernd Sido; Cornelia Seel; Achim Hochlehnert; Raoul Breitkreutz; Wulf Dröge
Journal:  Dig Dis Sci       Date:  2006-11-01       Impact factor: 3.487

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.